The actions of exogenous GLP-1 on brain reactivity to food cues have been largely investigated in obese and type 2 diabetic populations given the efficacy of long-acting GLP-1 analogs, such as liraglutide, in treating these metabolic conditions. Here, GLP1R is linked to type 2 diabetes mellitus.